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ABSTRACT
OBJECTIVE: To analyze the perception of and motivation for the chronic 
use of benzodiazepine among older adults.
METHODS: A qualitative study was conducted on 22 older adults living 
in Bambuí, MG, Southeastern Brazil, who were taking benzodiazepines 
and had the clinical and cognitive ability to respond to interview questions. 
The collected data were analyzed on the basis of the “signs, meanings, and 
actions” model.
RESULTS: The main reasons pointed out for the use of benzodiazepines 
were “nervousness”, “sleep problems”, and “worry” due to family and 
financial problems, everyday problems, and existential difficulties. None 
of the interviewees said that they used benzodiazepines in a dose higher 
than that recommended or had been warned by health professionals about 
any risks of their continuous use. Different strategies were used to obtain 
the prescription for the medication, and any physician would prescribe it, 
indicating that a bond was established with the drug and not with the health 
professional or healthcare service. Obtaining and consuming the medication 
turned into a crucial issue because benzodiazepine assumes the status of an 
essential food, which leads users to not think but sleep. It causes a feeling of 
relief from their problems such as awareness of human finitude and fragility, 
existential difficulties, and family problems.
CONCLUSIONS: Benzodiazepine assumes the characteristics of polyvalence 
among older adults, which extrapolate specific clinical indications, and of 
essentiality to deal with life’s problems in old age. Although it relieves 
the “nerves”, the chronic use of benzodiazepines buffers suffering and 
prevents older adults from going through the suffering. This shows important 
difficulties in the organization and planning of strategies that are necessary 
for minimizing the chronic use in this population.
DESCRIPTORS: Aged. Benzodiazepines therapeutic use Drugs of 
Continuous Use Health Knowledge, Attitudes, Practice. Qualitative 
Research.
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Benzodiazepines, which have been used in clinical 
practice since the 1960s, represent a class of medica-
tions with good anxiolytic potential and lower risks 
of dependence, drug-drug interaction, and death, even 
when taken at high doses.3 Nevertheless, they should 
be used with caution, particularly among older adults, 
because they have been associated with falls,15 exacer-
bation of cognitive decline, and sedation,9 particularly 
when used for extended periods.
International6 and national1 studies indicate a high prev-
alence of benzodiazepine consumption in the older adult 
population, particularly among women; this difference 
is usually less pronounced among older adults.6 North 
Americans6 tend to rely on benzodiazepines because of 
their tranquilizing properties and efficiency in control-
ling stress in old age. Among Brazilian older adults1,2 
the use of long half-life benzodiazepines associated 
RESUMO
OBJETIVO: Analisar a percepção e motivação do uso crônico de 
benzodiazepínicos entre idosos.
MÉTODOS: Estudo qualitativo desenvolvido com 22 idosos residentes em 
Bambuí, MG, sob uso de medicação benzodiazepínica e em condições clínicas 
e cognitivas para responder à entrevista. Os dados coletados foram analisados 
com base no modelo de “signos, significados e ações”.
RESULTADOS: As principais razões apontadas para o uso dos benzodiazepínicos 
foram “nervosismo”, “problemas de sono” e “preocupação”, decorrentes de 
problemas familiares, financeiros, dificuldades cotidianas e existenciais. Nenhum dos 
entrevistados referiu utilizar benzodiazepínicos acima das doses recomendadas nem 
foi alertado pelos profissionais acerca de quaisquer riscos sobre o seu uso continuado. 
Houve diversidade de estratégias na obtenção da prescrição do medicamento e 
qualquer médico fornecia a receita, o que indica que o vínculo é estabelecido com o 
medicamento e não com o profissional ou serviço de saúde. A obtenção e o consumo 
do medicamento tornam-se uma questão crucial, pois o benzodiazepínico assume a 
importância de um alimento essencial, que lhes permite não pensar e dormir. Oferece 
um alívio dos seus problemas, que incluem a consciência da finitude e da fragilidade 
humanas, dificuldades existenciais e familiares.
CONCLUSÕES: O benzodiazepínico assume características de polivalência 
entre os idosos, que extrapolam as indicações clínicas mais precisas, e de 
essencialidade para lidar com problemas da vida na velhice. Embora alivie o 
“nervoso”, o uso crônico de benzodiazepínicos tampona o sofrimento e impede 
a pessoa idosa de enfrentar o que ele representa. Isso mostra importantes 
dificuldades na organização e planejamento de estratégias necessárias para 
minimizá-lo nessa população.
DESCRITORES: Idoso. Benzodiazepinas, uso terapêutico. Medicamentos 
de Uso Contínuo. Conhecimentos, Atitudes e Prática em Saúde. Pesquisa 
Qualitativa.
INTRODUCTION
with sleep disorders and anxiety. Long-term use without 
specialized supervision1 has been reported to be signifi-
cantly greater among women also exhibiting symptoms 
of depression.2 A study performed with rural workers21 
indicated the use of psychotropic drugs as an attitude 
adopted to deal with “nervous problems”.
Gaining qualitative knowledge17 of the meaning of this 
use among older adults is crucial for the organization of 
healthcare services. In this study, we aimed to analyze 
the perception of and motivation for chronic benzodi-
azepine use among older adults.
METHODS
The present study had a qualitative approach and was 
performed on older adults participating in the Bambuí 
project (prospective population-based study), which 
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was developed in the municipality of Bambuí, MG, 
Southeastern Brazil. The cohort was formed in 1997. 
Details are described elsewhere.16
The survey was conducted in the urban area of Bambuí, 
state of Minas Gerais, Southeastern Brazil, which 
includes approximately 23 thousand inhabitants. 
According to official data,a the population of the munic-
ipality has undergone intense urbanization since 1950; 
the rural population reduced from 84.0% in 1950 to 
15.0% in 2010. It also exhibited accelerated aging, and 
the proportion of older adults showed a fivefold increase 
in 50 years. One-third of the population is living under 
poverty conditions.a The older adult population has a 
rural origin, has a low education level, and is strongly 
influenced by the Catholic church.11
There are no long-stay institutions for older adults in the 
municipality.11 The public healthcare network includes 
six Unidades Básicas de Saúde (UBS – basic health-
care units), each of which has a multiprofessional health 
team (one physician, one nurse, two nursing assistants, 
and six to seven community health agents), which is 
part of the Estratégia de Saúde da Família (ESF – 
Family Health Strategy). The Brazilian Unified Health 
System (SUS) also consists of a Health Center, a unit of 
the Center for Family Health support, two hospitals (one 
state hospital and one municipal hospital), and Posto 
Avançado de Estudos Emanuel Dias (Fiocruz), which 
is currently used for the collection of laboratory tests 
and the supervision of individuals chronically affected 
by Chagas disease.
The older adults for the study were selected among 
the participants of the seventh segment of the Bambuí 
project, and the inclusion criteria included being a 
current benzodiazepine user with clinical and cognitive 
abilities to respond to the interview questions.
The “signs, meanings, and actions” model developed 
by Corin et al5 was used to collect and analyze the data. 
The model allows the systematization of the context 
elements involved in the construction of the way older 
adults think about and act toward benzodiazepine use.
With its origin based on the definition of the Geertzian 
culture, this model seeks the systemization of the 
various elements of the context that influence the 
concretization of cultural logics.10 According to 
Geertz,10 culture is a universe of symbols and mean-
ings that allows a group to interpret their experience 
and to guide their actions. Hence, each community 
specifically builds its universe of problems, empha-
sizing some, prioritizing this or that explanation, and 
encouraging a certain type of reaction. This method5 
seeks to identify the signs, the meanings attributed 
to these signs, and the reactions that they trigger. 
Uchôa24 understands that the experience of the illness 
cannot be considered as a simple reflection of the 
pathological process in the biomedical sense of the 
term. It should be conceived as a cultural construc-
tion that is expressed in “specific ways of thinking and 
acting”. Kleinman13 emphasizes that the illness expe-
rience and the behaviors associated with it substan-
tially vary among societies, which is more important 
than the actual disease. These experiences, which are 
subjective and from the inner world of people, are 
built on the basis of cultural representations of the 
person, subjectivity, the body, the world, and life. 
All these representations contribute to modulate the 
illness experience of individuals.5 This understanding 
is supported by the idea that the perception of profes-
sionals is almost always linked to biomedical knowl-
edge, while the perception of the population is linked 
to a network of symbols articulating biomedical and 
cultural concepts.4,24
In total, 22 interviews were conducted at the residence 
of the older adults to reconstruct the universe of repre-
sentations (way of thinking) and of actions (ways of 
acting) associated with benzodiazepine use. The semi-
structured interviews were recorded and transcribed, 
always starting with the question: “Have you taken any 
medication in the last three months?”. In the case of an 
affirmative answer, this was followed by the question: 
“Do you remember which medications these were?”. 
Issues related to use and to the older adult’s percep-
tion of the medication were explored on the basis of 
the answers given to the initial questions.
The transcribed interviews were attentively read to 
identify significant units and create analytical categories 
for the construction of a coding scheme. Content and 
interaction between the different categories and subcat-
egories were analyzed, leading to the identification of 
the signs and meanings that the older adults attributed 
to benzodiazepine medication and the actions taken as 
a result of its use.
The survey was approved by the Ethics Committee of 
the Centro de Pesquisa René Rachou (René Rachou 
Research Center) according to the protocol 18/2010 
(CAAE: 0018.0.245.000-10). Participants signed an 
informed consent form.
RESULTS AND DISCUSSION
Out of the 22 older adults studied, four were men and 
18 were women, mostly married or widows/widowers, 
with children, and on a low income. Six were illiterate, 
three interviewees had more than eight years of educa-
tion, and the others had between 1-5 complete years 
of schooling.
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Obtaining benzodiazepine (a controlled drug) requires 
the possession of a medical prescription, as stated in 
the pertinent legislation. Prescriptions were written by 
non-psychiatrist physicians because the city did not 
have this type of specialist at the time. Other studies 
have shown the same practice.18
The most commonly reported benzodiazepine was 
clonazepam, followed by bromazepam, lorazepam, or 
diazepam. The brand name of the medication has been 
omitted to preserve confidentiality.
Participants reported chronic consumption of the medi-
cation (from six months to 40 years); none of them 
used benzodiazepines at a dose higher than that recom-
mended by the clinical and pharmacological guidelines, 
although they reported changing the type of benzodi-
azepine consumed.
Nerves under control, guaranteed relief
Participants, who came from lower classes and many 
of whom from rural regions, associated “nerves” as the 
cause of their sleeping difficulties:
“It [the medication] was prescribed to treat the ner-
vous tension that we felt. Because my husband fell ill, 
we went to (a nearby city) (...) and spent everything 
we had. (...) They had to prescribe me a sedative. 
(...) They took me to the doctor, and he prescribed 
Clonazepam. It worked. I wasn’t sleeping.” (F16, 
age 74, widow, a user for 22 years)
“Ah, I’m a very nervous person. If I get nervous, 
then that’s it: I can’t sleep. There are days when we 
feel nervous for no reason. At other times, we keep 
thinking about being old, about our children scat-
tered here and there (...).” (F13, age 76, married, a 
user for 20 years)
When talking about his “nerves”, a man explained that 
he and his daughter took the same medication:
“She also suffers from nerves, poor thing. Everyone’s 
nervous, and they never give the slightest sign of it. 
They all seem happy.” (M3, single, age 74, a user 
for four years)
This “lack of demonstrativeness” shows a strategy of 
the working class, which exhibits a spartan attitude 
toward suffering, expressing it differently.4 When ques-
tioned about the reason why they use the medication, 
men and women mentioned “nerves”, “nervousness”, 
and “confusion”, which are indicative of sleep prob-
lems, concern about the family, death of loved ones, 
and pain, as in these reports:
“Because I wasn’t sleeping. (...) I don‘t know if it’s 
because I keep thinking about life that we’re on our 
own. There are days when not a single person comes 
around here to talk to me. When they do, someti-
mes it’s just to annoy me.” (F10, age 86, single, a 
user for two years)
“I had something really bad, I was sick, a huge lump 
on my body. (...) I was so worried. I couldn’t sleep. 
Then he prescribed this medication. (...) I didn’t 
feel anything after that.” (F4, age 69, married, a 
user for six months)
“I get nervous, so the doctor prescribed me the medi-
cation, to sleep. I’d spend sleepless nights, suffering 
from those nerves, that feeling of confusion.” (M4, 
age 73, married, a user for 15 years)
The interviewees explained that they seek the rapid 
relief that they experience “in just half an hour” (M4) 
and also the chance to “not think” (F4) about the 
“nervousness” that afflicts them and about managing 
to sleep. However, there were people who used the 
medication without referring to difficulties in sleeping:
“I sleep well. It’s only because of my head. For old 
people, a sedative helps us bear the pain and the 
problems better... Not that I’m a nervous person or 
that I need it....” (F8, age 68, married, a user for 
more than five years)
This lady argued the following:
“They say I take too much medication; I say: ‘God 
and medicine allow us to continue living’.” (F13, 
age 76, married, a user for 20 years)
These older adults seek and find in benzodiazepine 
a powerful strategy to deal with “nervousness” and 
cope with their everyday problems. Duarte8 describes 
“nerves”, which is a privileged code of expression of 
the troubles of Brazilian lower classes, as a relational 
representation of the person with their life context, 
unlike that of certain social segments that are more 
attuned to the western psychologized and biomedi-
calizing view of psychiatry. This author attributes to 
the code of nervousness a true and integrated phys-
ical and moral representation of the person who can 
only exist within a specific cultural scenario and 
challenges the biomedical reductionism of the term 
“mental illness”. The author’s medical anthropolog-
ical reading of nervousness opposes the following 
theories: a) biomedical, whereby these phenomena 
merely refer to the organic expression of mental 
illness; b) psychologizing, which sees them as an 
expression of emotions and of individual psyche; and 
c) sociological, which sees them as a reflection of 
class and/or gender conflicts as well as the resulting 
domination associated with them.8 All ethnographic, 
interpretative, and statistical literature about nervous 
states is somehow related to the issue of labor and 
social reproduction.8
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Historically, a division of roles and spaces has been 
recognized, in which men had duties performed in 
the public and external space, while women were 
predominantly destined to private and domestic 
spaces. Therefore, considering the interdependence 
between gender and social class, this scenario was 
profoundly modified when women began leaving the 
house to work.8,19,23 However, no major differences were 
observed in men’s and women’s understanding of the 
chronic use of the medication, perhaps because men and 
women were out of the job market in which men were 
retired and women were housewives who had mostly 
never worked outside the home.
By admitting that the problem that led to the use of the 
medication no longer exists, this woman told us why 
she is not able to stop taking it:
“I wasn’t sleeping or eating. I’d just think about the 
consequences because he (her son) drank, and the 
others picked on him. (...) He stopped drinking and 
I got better. (...) I think these medications are.. [sic] 
like a drug (...) You get addicted to that medication. 
So I’d like to go a day without taking it to see if I 
manage to sleep. (...) Just thinking about not taking it, 
I don’t think I’ll manage to sleep. (...) I don’t let it run 
out. The blister pack there has about 10 pills left....” 
(F12, age 89, widow, user for more than two years)
Although the medication means “a drug” that is “addic-
tive”, the interviewees did not report consumption at 
abusive doses or frequencies. A similar positive eval-
uation was observed in national20 and international 
studies.21 With regard to the negative effects of the 
medication, the following was reported:
“I got much worse; the malaise, the despondency 
(...) So I’m rather dubious. I said: ‘I’m going to stop 
taking the medication’ (...) thinking about trying 
it out. I’m going to stop taking it and tell the doc-
tor I’ve stopped because you can’t continue taking 
medication like that indiscriminately.” (F8, age 68, 
married, a user for more than five years)
Continued use does not provoke any fears:
“I’ve been using this medication for a long time, 
and I don’t have any problems.” (M3, age 74, sin-
gle, a user for four years)
“Nothing negative (...) I don’t think I can stop. 
Because they’re doing me good: I didn’t use to talk 
to anybody. I didn’t know how to have a proper con-
versation. It was horrible.” (F1, age 75, widow, a 
user for more than five years)
The use of benzodiazepines is restricted not only to their 
biochemical effects but also to the social and cultural 
interaction4,8 experienced by the older adults with 
regard to their oral communication. Similar evidence 
of significant psychological dependency, concomi-
tantly with the underestimation or denial of potential 
side effects of benzodiazepines, was detected among 
older North American adults, with a strong resistance 
to withdrawal of the medication.6,7
“It’s better to go without rice than to go without it 
(benzodiazepine).” (F16, age 74, widow, a user for 
more than 22 years)
When seeking help, older adults receive the prescription 
for the medication to calm their nerves, and they will 
possibly use it indefinitely because in their speech, the 
signs of “relief”, “goodness”, and “not thinking” refer 
to the perceived effects of benzodiazepine. In light of 
the existential difficulties, this “relief” can be just as 
important as everyday “rice”. Therefore, this represents 
a scenario of chronic use of the medication, similar to 
that indicated in the study of Rozemberg21 in which 
the medication serves as a “chemical prosthesis” that 
controls a state of mental disturbance, “nervousness” 
– and somehow compensates for the lack of prospects. 
Benzodiazepine has a status of an essential food and 
serves to temper the awareness of the person’s own 
mortality and of human fragility when facing aging, 
solitude, family problems, and situations from which 
they see no way out.11 For older adults, the availability 
of the professional who provides the prescription 
matters more than their specialized knowledge:
“I don’t have a particular doctor. (...) Any doctor 
can prescribe the medication (benzodiazepine) for 
us.” (F16, age 74, widow, a user for 22 years)
In most cases, there was not even a need for regular 
doctor’s appointments because “anyone” can provide 
the prescription. A similar result was observed among 
Brazilian farm workers.5 The access to the prescrip-
tion depends more on personal and family relationships 
and/or on the mediation of employees of the actual 
healthcare service; this process is not always simple:
“When I need a prescription, I don’t even go there (to 
the healthcare service). She (female employee of the 
service) already knows. I call them and he delivers 
the medication to his secretary, a lady who lives right 
near me; she brings it to me and I continue taking it.” 
(F1, age 75, widow, user for more than five years)
“There are days when they (female employees of the 
service) are really nice. They enter the building and 
the doctor walks by and stamps the prescription for 
us. Sometimes though, they are a bit nervous, so we 
schedule an appointment.” (F16, age 74, widow, a 
user for 22 years)
This range of different mechanisms and strategies to 
obtain benzodiazepine indicates that a bond is not estab-
lished with the professional or the healthcare service but 
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rather with the medication itself. The need to present 
a prescription is perceived by the interviewees as an 
obstacle and not as a precaution.
“The doctor only prescribed it once, and I conti-
nued taking it (...). I didn’t get the benzodiazepine 
(at the center), I’d buy it (...) Later on, the pharma-
cist wouldn’t do it anymore (sell without a prescrip-
tion) (...) He said: ‘now it has to be with a medi-
cal prescription’. (...) if there were another phar-
macist who didn’t require a medical prescription, 
then I’d buy it from him.” (F7, age 70, married, a 
user for two years)
These data are in accordance with those of another 
study18 in which older adults reported easy access to 
the medication and prescription without the need for a 
formal doctor’s appointment or medical guidance about 
the necessary precautions during treatment.
None of the participants referred to any type of 
warning regarding this medication, which contradicts 
the medical literature that emphasizes on the risks of 
benzodiazepine use in the older adult population.3,9,15 
Only one woman reported that her daughter was warned 
by the “man from the drugstore” that this medication 
would not be suitable for an older adult. A Finnish 
study conducted on older adults who were chronic 
users showed that the guidance about the risks involved 
in its consumption reduced the regular use of benzo-
diazepines by 30.0%. On the other hand, an increase 
was observed among those who had not received the 
same guidance.22 Such interventions were more effi-
cient among older adults of a relatively younger age 
and women.22 Cook et al6,7 noted that older adults with 
a greater daily frequency of benzodiazepine use and 
greater anxiety were less predisposed to reduce dosages 
or to plan ahead to stop taking benzodiazepine in the 
United States. With regard to the reason for not inter-
rupting this medication, two women spoke about the 
guidance they received:
“Some days I talk to him (the doctor) (about stop-
ping taking it), but he’s difficult to persuade. He 
tells me to take it again.” (F7, age 70, married, a 
user for two years)
“I don’t know. Why is it a controlled substance? Is it 
because we can’t be cured? Is that the reason? (...) 
They say ‘You can stop taking that medication’. I say 
‘It was the doctor who prescribed it’. (...) I want to 
(stop). I’ve told him (the doctor) before: ‘Doctor, I 
can’t deal with this dosage...’ (referring to what she 
heard from the prescriber) ‘I’m not asking you if you 
can or can’t. You’ll buy the medication and take it’ 
(laughing).” (F10, age 86, single, a user for two years)
In addition, the medical professional did not answer 
her questions about the medication:
“I don’t know if it’s because of this medication, I’ve 
already spoken to him (doctor), but he didn’t say 
anything.” (F10, age 86, single, a user for two years)
This communication barrier indicates the clash between 
secular culture, a person suffering from “nerves”, and 
the professional culture that is almost completely sepa-
rated from the nerves model, and it is also committed 
to some versions of contemporary psychologized 
knowledge of the person.19 The risks of a difference 
of opinion are greater when the outline of problems 
is poorly defined and subjected to multiple interpre-
tations and conducts, as in the case of mental health 
problems.13 The interrogation about the meaning of the 
illness, in particular, is not restricted to medical infor-
mation. Relationships between medical knowledge and 
commonsense conceptions may be established in both 
directions without depending on a single direction but 
rather “swinging” between the erudite thinking (of the 
professional) and commonsense thinking.12
Supplies and demands for services are located in a 
space of potential negotiation that largely determines 
the decision to interrupt or continue the treatment and 
the type of response to it. Regardless of the conver-
gences and distances between the fields of perceptions, 
expectations, and practices of laypersons and profes-
sionals, services may not correspond to the needs of 
the assisted populations.13
CONCLUSIONS
Among older adults, “nerves”, this troubling, intangible, 
and incurable condition that their existential and family 
problems represent and that deprives them from sleep and 
peace of mind, can be “relieved” by the chronic use of 
benzodiazepines. The feeling of well-being that the medi-
cation causes “is addictive”, and becomes just as indis-
pensable as their daily “rice”, even if it does not solve the 
root causes of their problems, which are related to their life 
context. Therefore, it is difficult to plan strategies to mini-
mize the chronic use of this medication because by treating 
“nerves” as a disease, the healthcare service buffers the 
pain of life and simultaneously prevents the person from 
facing and attempting to address their problems.
This scenario requires a re-evaluation of the public policies 
that provide both support to professionals and other forms 
of care and advice regarding the meaning of the underlying 
“nervousness”. This is to cease the acritical and indefinite 
prescription of these legal drugs to the population who is 
known to be vulnerable to their adverse effects. 
Otherwise, older adults have no choice but to continue 
visiting healthcare services in search of prescriptions for 
“an addictive drug” that “anyone” can prescribe. Then, 
they will continue taking benzodiazepines to help them 
“to not think” but “sleep”.
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